Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01735981 · ClinicalTrials.gov registry record · NA
The Effect of Video Game Exercise on Dynamic Balance and Gait in Individuals With Huntington's Disease
A NA study of Huntington's Disease, sponsored by Anne Kloos.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT01735981 is a NA study of Huntington's Disease that has completed, run by Anne Kloos. The registered enrollment target is 24 participants, below the 4,791-participant average among 8 other Huntington's Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01735981, a NA study of Huntington's Disease, has completed, sponsored by Anne Kloos.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
To examine the benefits of using a video-game, Dance, Dance, Revolution, as an exercise modality to improve gait and balance in individuals with Huntington's disease.
Conditions Studied
Interventions
- OTHER Video game exercise using Dance Dance Revolution
- OTHER hand-held video game
Study Locations (1)
Ohio
- The Ohio State University Atwell Hall - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-06 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01735981
The ClinicalTrials.gov registry entry for NCT01735981 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,791-participant average among 8 other Huntington's Disease trials with a reported enrollment target (99% lower). The listed sponsor is Anne Kloos, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Huntington's Disease appearing as the primary indexed condition, and to 2 interventions - of which Video game exercise using Dance Dance Revolution is the first listed.
NCT01735981 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT01735981 about?
NCT01735981 is a clinical study titled "The Effect of Video Game Exercise on Dynamic Balance and Gait in Individuals With Huntington's Disease". To examine the benefits of using a video-game, Dance, Dance, Revolution, as an exercise modality to improve gait and balance in individuals with Huntington's disease.
What is the current status of trial NCT01735981?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2008-06. Estimated completion is 2012-06.
What conditions does trial NCT01735981 study?
This clinical trial studies the following conditions: Huntington's Disease.
What interventions are being tested in trial NCT01735981?
The interventions under investigation include: Video game exercise using Dance Dance Revolution (OTHER), hand-held video game (OTHER).
Who is sponsoring clinical trial NCT01735981?
This trial is sponsored by Anne Kloos, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01735981 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Huntington's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
RECRUITING
-
Child to Adult Neurodevelopment in Gene Expanded Huntington's Disease
RECRUITING
-
HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
RECRUITING
-
Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease
ACTIVE NOT RECRUITING · Phase 1
-
A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function
COMPLETED · Phase 1
-
Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.